578 related articles for article (PubMed ID: 32810619)
1. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.
Yang Z; Zhang Q; Yu L; Zhu J; Cao Y; Gao X
J Ethnopharmacol; 2021 Jan; 264():113249. PubMed ID: 32810619
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive Breast Cancer: A comprehensive Literature Review.
Yu Q; Xu C; Song J; Jin Y; Gao X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117322. PubMed ID: 37866466
[TBL] [Abstract][Full Text] [Related]
3. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
[TBL] [Abstract][Full Text] [Related]
4. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
5. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract][Full Text] [Related]
6. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
9. Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
Yang X; Li F; Shi Y; Wu Y; Yang R; Liu X; Zhang Y; Zhang G; Ma M; Luo Z; Han X; Xie Y; Liu S
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):763-775. PubMed ID: 38516703
[TBL] [Abstract][Full Text] [Related]
10. The signaling pathways of traditional Chinese medicine in promoting diabetic wound healing.
Zhou X; Guo Y; Yang K; Liu P; Wang J
J Ethnopharmacol; 2022 Jan; 282():114662. PubMed ID: 34555452
[TBL] [Abstract][Full Text] [Related]
11. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
Wu C; Qiu S; Liu P; Ge Y; Gao X
J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
[TBL] [Abstract][Full Text] [Related]
12. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
[TBL] [Abstract][Full Text] [Related]
13. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling.
Shahi Thakuri P; Gupta M; Singh S; Joshi R; Glasgow E; Lekan A; Agarwal S; Luker GD; Tavana H
BMC Cancer; 2020 Jan; 20(1):4. PubMed ID: 31898540
[TBL] [Abstract][Full Text] [Related]
14. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
Costa RLB; Han HS; Gradishar WJ
Breast Cancer Res Treat; 2018 Jun; 169(3):397-406. PubMed ID: 29417298
[TBL] [Abstract][Full Text] [Related]
15. Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A.
Kuo YH; Chiang EI; Chao CY; Rodriguez RL; Chou PY; Tsai SY; Pai MH; Tang FY
Mol Cancer Ther; 2017 Mar; 16(3):480-493. PubMed ID: 27956520
[TBL] [Abstract][Full Text] [Related]
16. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
Youns M; Hoheisel JD; Efferth T
Curr Drug Discov Technol; 2010 Mar; 7(1):37-45. PubMed ID: 20156142
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets of triple-negative breast cancer: a review.
Jamdade VS; Sethi N; Mundhe NA; Kumar P; Lahkar M; Sinha N
Br J Pharmacol; 2015 Sep; 172(17):4228-37. PubMed ID: 26040571
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
20. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]